HopeStage
Back to overview

ADHD studies

Topics
More filters

ADHD

Attention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.

1811studies shown
Showing 661-672 of 1,811
Drug study icon
CompletedNCT04027361

Amphetamine Extended Release Tablets and Driving Performance in Subjects With Attention Deficit/Hyperactivity Disorder (ADHD)

Official study title

Driving Performance in Patients Aged 18 to 25 Years With Attention-Deficit/Hyperactivity Disorder (ADHD) After a Single-Dose of Amphetamine Extended-Release Tablets: A Pilot, Double-Blind, Placebo-Controlled Study

This study has finished and is no longer accepting participants.

In Boston
ADHDMedication studyAges 18–25
Countries
United States
Sponsor
Tris Pharma, Inc.
Device study icon
Active Not RecruitingNCT05805176

An Adjunct Study to Assess Guided ADHD Therapy for Managing the Extent and Severity of Symptoms

Official study title

An Adjunct Study to Assess Guided ADHD Therapy for Managing the Extent and Severity of Symptoms - A Prospective, Multicenter, Open Label, Single Arm, Intervention Study to Assess Efficacy and Safety of an At-home, Game-based Digital Therapy for Treating Clinical Symptoms of Adult Patients With Attention-Deficit/Hyperactivity Disorder (ADHD)

This study is no longer accepting new participants.

Multiple locations, including Jacksonville
ADHDDevice studyAges 18–55
Countries
United States
Sponsor
Lumos Labs, Inc.
Drug study icon
CompletedNCT01876719

AR08 for Treatment of ADHD in Children

What is this study about?

Researchers compared AR08 and placebo to find out how the approaches affected ADHD symptoms in children with ADHD.

This study has finished and is no longer accepting participants.

Multiple locations, including Brandenton
ADHDMedication studyAges 6–17
Countries
United States
Sponsor
Arbor Pharmaceuticals, Inc.
Other study type icon
CompletedNCT01482026

Attention-Deficit Hyperactivity Disorder (ADHD) Rating Scale and Epilepsy

Official study title

Sensitivity of ADHD-IV Rating Scale in the Evaluation of the Evolution of Attention Disorders Associated With Childhood Epilepsy : a Validation Study

This study has finished and is no longer accepting participants.

Multiple locations, including Amiens
ADHDInterventional studyAges 6–16
Countries
France
Sponsor
Hospices Civils de Lyon
Behavioral study icon
CompletedNCT03015636

Better Sleep in Psychiatric Care - ADHD.

Official study title

Better Sleep in Psychiatric Care - ADHD. A Randomized Naturalistic Study of a Psychological Group Treatment for Sleep Problems in Psychiatric Patients With Attention Deficit Hyperactivity Disorder.

This study has finished and is no longer accepting participants.

In Stockholm
ADHDBehavioural studyAges 18+
Countries
Sweden
Sponsor
Karolinska Institutet
Drug study icon
UnknownNCT06542887

Black Seed Oil in ADHD

Official study title

Efficacy and Safety of Black Seed Oil as Adjunctive Therapy in Pediatrics With Attention-Deficit/Hyperactivity Disorder

Current recruitment status is unconfirmed.

Location not clearly listed
ADHDMedication studyAges 6–12
Countries
Sponsor
Ain Shams University
Behavioral study icon
CompletedNCT06351930

CBT for Insomnia in Adolescents With ADHD

Official study title

Efficacy of Cognitive Behaviour Therapy for Insomnia (CBT-I) in Adolescents With Attention Deficit Hyperactivity Disorder (ADHD): A Randomized Controlled Trial

This study has finished and is no longer accepting participants.

In Hong Kong
ADHDBehavioural studyAges 12–18
Countries
China
Sponsor
The University of Hong Kong

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.